Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2010 1
2011 2
2012 1
2013 1
2014 1
2015 6
2016 4
2017 7
2018 3
2019 3
2020 6
2021 6
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Sirtuin activation targets IDH-mutant tumors.
Miller JJ, Fink A, Banagis JA, Nagashima H, Subramanian M, Lee CK, Melamed L, Tummala SS, Tateishi K, Wakimoto H, Cahill DP. Miller JJ, et al. Among authors: nagashima h. Neuro Oncol. 2021 Jan 30;23(1):53-62. doi: 10.1093/neuonc/noaa180. Neuro Oncol. 2021. PMID: 32710757 Free PMC article.
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.
Spitzer A, Gritsch S, Nomura M, Jucht A, Fortin J, Raviram R, Weisman HR, Gonzalez Castro LN, Druck N, Chanoch-Myers R, Lee JJY, Mylvaganam R, Lee Servis R, Fung JM, Lee CK, Nagashima H, Miller JJ, Arrillaga-Romany I, Louis DN, Wakimoto H, Pisano W, Wen PY, Mak TW, Sanson M, Touat M, Landau DA, Ligon KL, Cahill DP, Suvà ML, Tirosh I. Spitzer A, et al. Among authors: nagashima h. Cancer Cell. 2024 Apr 2:S1535-6108(24)00093-X. doi: 10.1016/j.ccell.2024.03.008. Online ahead of print. Cancer Cell. 2024. PMID: 38579724
Multidrug chemotherapy, whole-brain radiation and cytarabine therapy for primary central nervous system lymphoma in elderly patients with dose modification based on geriatric assessment: study protocol for a phase II, multicentre, non-randomised study.
Yamasaki F, Fudaba H, Asano K, Sasayama T, Natsumeda M, Shimabukuro T, Taguchi K, Koizumi S, Nakayama N, Fujii K, Nishibuchi I, Sugiyama K, Yoshida K, Yonezawa U, Yasutomo M, Kawasaki Y, Kakuta K, Katayama K, Tanaka K, Nagashima H, Tsukamoto Y, Ideguchi M, Nishizaki T, Kurozumi K, Hosoya T, Akita T, Kambe A. Yamasaki F, et al. Among authors: nagashima h. BMJ Open. 2023 Apr 24;13(4):e071350. doi: 10.1136/bmjopen-2022-071350. BMJ Open. 2023. PMID: 37094899 Free PMC article.
Glioma cells require one-carbon metabolism to survive glutamine starvation.
Tanaka K, Sasayama T, Nagashima H, Irino Y, Takahashi M, Izumi Y, Uno T, Satoh N, Kitta A, Kyotani K, Fujita Y, Hashiguchi M, Nakai T, Kohta M, Uozumi Y, Shinohara M, Hosoda K, Bamba T, Kohmura E. Tanaka K, et al. Among authors: nagashima h. Acta Neuropathol Commun. 2021 Jan 19;9(1):16. doi: 10.1186/s40478-020-01114-1. Acta Neuropathol Commun. 2021. PMID: 33468252 Free PMC article.
2-Hydroxyglutarate magnetic resonance spectroscopy in adult brainstem glioma.
Iwahashi H, Nagashima H, Tanaka K, Uno T, Hashiguchi M, Maeyama M, Somiya Y, Komatsu M, Hirose T, Itoh T, Sasaki R, Sasayama T. Iwahashi H, et al. Among authors: nagashima h. J Neurosurg. 2023 Jan 27;139(2):355-362. doi: 10.3171/2022.12.JNS221954. Print 2023 Aug 1. J Neurosurg. 2023. PMID: 36708540
IDH-mutant gliomas harbor fewer regulatory T cells in humans and mice.
Richardson LG, Nieman LT, Stemmer-Rachamimov AO, Zheng XS, Stafford K, Nagashima H, Miller JJ, Kiyokawa J, Ting DT, Wakimoto H, Cahill DP, Choi BD, Curry WT. Richardson LG, et al. Among authors: nagashima h. Oncoimmunology. 2020 Aug 20;9(1):1806662. doi: 10.1080/2162402X.2020.1806662. Oncoimmunology. 2020. PMID: 32923170 Free PMC article.
CDKN2A/B homozygous deletion sensitizes IDH-mutant glioma to CDK4/6 inhibition.
Nasser AM, Melamed L, Wetzel E, Chang CC, Nagashima H, Kitagawa Y, Muzyka L, Wakimoto H, Cahill DP, Miller JJ. Nasser AM, et al. Among authors: nagashima h. Clin Cancer Res. 2024 May 8. doi: 10.1158/1078-0432.CCR-24-0562. Online ahead of print. Clin Cancer Res. 2024. PMID: 38718141
Medial lingual lymph node metastasis in carcinoma of the tongue.
Eguchi K, Kawai S, Mukai M, Nagashima H, Shirakura S, Sugimoto T, Asakage T. Eguchi K, et al. Among authors: nagashima h. Auris Nasus Larynx. 2020 Feb;47(1):158-162. doi: 10.1016/j.anl.2019.03.003. Epub 2019 Mar 29. Auris Nasus Larynx. 2020. PMID: 30929928
46 results